Albuquerque – Independent U.S. specialist publisher LabNews Media LLC has reshaped the editorial leadership of its life sciences news portfolio. Vlad Georgescu and Marita Vollborn, two long-standing science and business journalists with a strong track record in investigative reporting, have been named Editors-in-Chief of labnews.io and its sister platform labnews.ai.
Profiles and reputation
Georgescu and Vollborn are regarded as experienced voices in science, healthcare and economic reporting, with decades of work spanning complex topics such as biotechnology, laboratory medicine, pharmaceuticals, environmental health and digital transformation in healthcare. Their journalism has included in‑depth investigations, long-form analyses and explanatory pieces aimed at both expert and general audiences.
Both editors have also authored several non-fiction books on science, health policy and economic issues, which have been acquired by major institutional libraries, including parliamentary and academic collections. This presence in reference libraries underscores their reputation as established authors whose work is used in professional and policy contexts.
Role at labnews.io and labnews.ai
As Editors-in-Chief, Georgescu and Vollborn will be responsible for the editorial strategy, topic selection and quality assurance of labnews.io and labnews.ai. The platforms focus on evidence-based reporting on biotechnology, analytics, laboratory medicine, pharmaceuticals, AI in medicine and the broader life sciences sector, with a particular emphasis on regulatory developments, innovation pipelines and risks to patients and public health.
Their remit includes the coordination of investigative projects, the evaluation of scientific and regulatory sources, and the development of editorial standards for dealing with politically or economically sensitive topics. They are also expected to expand the use of AI tools in research and analysis, while maintaining strict journalistic oversight and transparency about methods and sources.
Editorial line and standards
Under the new leadership, LabNews aims to strengthen its profile as an independent, non-corporate news provider that relies on documented evidence, primary sources and scientific publications rather than press releases and industry narratives. The editorial team is committed to clear source attribution, conflict-of-interest disclosure and the separation of reporting, commentary and opinion.
The platforms publish in English and German, targeting readers in the laboratory industry, biotech companies, research institutions, universities, regulatory agencies, as well as interested members of the public. The editorial line emphasises accessibility without sacrificing technical precision, combining data-driven reporting with explanatory background pieces and interviews with subject-matter experts.
International reach and focus
LabNews Media LLC distributes its content to readers in more than 100 countries and seeks to address cross-border topics such as global supply chains in laboratory diagnostics, international regulation of AI in medicine, space biology and planetary health. Under Georgescu and Vollborn, the editorial team plans to further expand coverage of the interface between science, politics and business, including the influence of lobbying, the transparency of regulatory processes and the societal impact of new technologies.
In addition to daily news and analyses, the editors intend to launch thematic series and dossiers, for example on digital health infrastructure, preparedness for biological threats, and the ethical implications of AI-supported diagnostics and research. The goal is to provide context that helps readers understand not only individual developments but also the systemic forces shaping the life sciences and healthcare sectors.
